Hakim Echchannaoui

1.1k total citations
23 papers, 797 citations indexed

About

Hakim Echchannaoui is a scholar working on Immunology, Epidemiology and Oncology. According to data from OpenAlex, Hakim Echchannaoui has authored 23 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 7 papers in Epidemiology and 6 papers in Oncology. Recurrent topics in Hakim Echchannaoui's work include Immune Response and Inflammation (9 papers), Pneumonia and Respiratory Infections (6 papers) and Immune Cell Function and Interaction (6 papers). Hakim Echchannaoui is often cited by papers focused on Immune Response and Inflammation (9 papers), Pneumonia and Respiratory Infections (6 papers) and Immune Cell Function and Interaction (6 papers). Hakim Echchannaoui collaborates with scholars based in Germany, Switzerland and United States. Hakim Echchannaoui's co-authors include Régine Landmann, Stephen L. Leib, Karl Frei, Werner Zimmerli, Christian Schnell, Serge Rivest, Nathalie Laflamme, Maryse Letièmbre, Fabrizia Ferracin and Matthias Theobald and has published in prestigious journals such as Blood, The Journal of Infectious Diseases and American Journal Of Pathology.

In The Last Decade

Hakim Echchannaoui

22 papers receiving 784 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hakim Echchannaoui Germany 15 469 243 158 156 117 23 797
Laure Janot France 10 356 0.8× 93 0.4× 84 0.5× 214 1.4× 36 0.3× 10 725
David Torres France 10 733 1.6× 216 0.9× 57 0.4× 193 1.2× 20 0.2× 11 1.0k
Megumi Inomata Japan 14 269 0.6× 231 1.0× 110 0.7× 254 1.6× 27 0.2× 30 725
Lorna Edwards United Kingdom 15 612 1.3× 376 1.5× 41 0.3× 200 1.3× 82 0.7× 19 1.0k
Stefan Dreher Germany 10 610 1.3× 143 0.6× 75 0.5× 307 2.0× 21 0.2× 13 914
M W Vermeulen United States 13 519 1.1× 284 1.2× 74 0.5× 299 1.9× 23 0.2× 19 1.1k
R. Lakshman Chelvarajan United States 15 366 0.8× 129 0.5× 25 0.2× 159 1.0× 59 0.5× 23 669
Bas Baaten United States 16 461 1.0× 281 1.2× 30 0.2× 222 1.4× 38 0.3× 23 956
Mary Speir Australia 13 295 0.6× 111 0.5× 84 0.5× 408 2.6× 19 0.2× 15 708

Countries citing papers authored by Hakim Echchannaoui

Since Specialization
Citations

This map shows the geographic impact of Hakim Echchannaoui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hakim Echchannaoui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hakim Echchannaoui more than expected).

Fields of papers citing papers by Hakim Echchannaoui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hakim Echchannaoui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hakim Echchannaoui. The network helps show where Hakim Echchannaoui may publish in the future.

Co-authorship network of co-authors of Hakim Echchannaoui

This figure shows the co-authorship network connecting the top 25 collaborators of Hakim Echchannaoui. A scholar is included among the top collaborators of Hakim Echchannaoui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hakim Echchannaoui. Hakim Echchannaoui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferreira, Edite Antunes, Matthias Bros, Oliver Kriege, et al.. (2025). Case Report: Late-onset primary hemophagocytic lymphohistiocytosis leading to the diagnosis of Griscelli syndrome type 2 in a young woman with phenotypically inapparent partial albinism. Frontiers in Immunology. 16. 1604460–1604460. 1 indexed citations
2.
Echchannaoui, Hakim, et al.. (2025). Tumor-Infiltrating Lymphocytes, CAR-, and T-Cell Receptor-Modified T Cells in Solid Cancer Oncology. Oncology Research and Treatment. 48(5). 294–304.
3.
Almeida, Luís, Daniele C. Nascimento, Luis Eduardo Alves Damasceno, et al.. (2025). The Streptomyces Metabolite Thiostrepton Inhibits Regulatory T Cell Differentiation and Function to Boost Antitumor Immune Responses. European Journal of Immunology. 55(8). e70035–e70035. 1 indexed citations
4.
Bohl, Stephan, Catharina Lahrmann, Linda Kessler, et al.. (2022). The Menin Inhibitor Ziftomenib (KO-539) Synergizes with Agents Targeting Chromatin Regulation or Apoptosis and Sensitizes AML with MLL Rearrangement or NPM1 Mutation to Venetoclax. Blood. 140(Supplement 1). 6226–6227. 1 indexed citations
5.
Werner, Anke, Hakim Echchannaoui, Alice Habermeier, et al.. (2021). Inhibition of Arginase 1 Liberates Potent T Cell Immunostimulatory Activity of Human Neutrophil Granulocytes. Frontiers in Immunology. 11. 617699–617699. 35 indexed citations
6.
Ferreira, Edite Antunes, Alexander Lang, Danuta Galetzka, et al.. (2021). Δ133p53α enhances metabolic and cellular fitness of TCR-engineered T cells and promotes superior antitumor immunity. Journal for ImmunoTherapy of Cancer. 9(6). e001846–e001846. 12 indexed citations
7.
Werner, Anke, Hakim Echchannaoui, Johanna Rupp, et al.. (2019). Cationic Amino Acid Transporter-1-Mediated Arginine Uptake Is Essential for Chronic Lymphocytic Leukemia Cell Proliferation and Viability. Frontiers in Oncology. 9. 1268–1268. 36 indexed citations
8.
Guezguez, Borhane, et al.. (2018). p53 Isoform D133p53a: A Novel Transcriptional Enhancer of T-Cell Effector Function to Improve T-Cell Based Cancer Immunotherapy. Blood. 132(Supplement 1). 3489–3489. 2 indexed citations
9.
Echchannaoui, Hakim, Jutta Petschenka, Edite Antunes Ferreira, et al.. (2018). A Potent Tumor-Reactive p53-Specific Single-Chain TCR without On- or Off-Target Autoimmunity In Vivo. Molecular Therapy. 27(1). 261–271. 10 indexed citations
10.
Engelhardt, Mélanie, Hakim Echchannaoui, Marc S. Raab, et al.. (2018). IL-10 inducible CD8+ regulatory T-cells are enriched in patients with multiple myeloma and impact the generation of antigen-specific T-cells. Cancer Immunology Immunotherapy. 67(11). 1695–1707. 15 indexed citations
11.
Klobuch, Sebastian, Shao‐An Xue, Matthias Birtel, et al.. (2016). An optimized single chain TCR scaffold relying on the assembly with the native CD3-complex prevents residual mispairing with endogenous TCRs in human T-cells. Oncotarget. 7(16). 21199–21221. 29 indexed citations
12.
Echchannaoui, Hakim, Alexander Desuki, Alice Habermeier, et al.. (2015). Interfering with Arginine Metabolism As a New Treatment Strategy for Multiple Myeloma. Blood. 126(23). 3005–3005. 1 indexed citations
13.
Echchannaoui, Hakim, Stephen L. Leib, Ulf Neumann, & Régine Landmann. (2007). Adjuvant TACE inhibitor treatment improves the outcome of TLR2-/-mice with experimental pneumococcal meningitis. BMC Infectious Diseases. 7(1). 25–25. 22 indexed citations
14.
Letièmbre, Maryse, Hakim Echchannaoui, Fabrizia Ferracin, Serge Rivest, & Régine Landmann. (2005). Toll-like receptor-2 deficiency is associated with enhanced brain TNF gene expression during pneumococcal meningitis. Journal of Neuroimmunology. 168(1-2). 21–33. 21 indexed citations
15.
Echchannaoui, Hakim, et al.. (2005). Regulation of Streptococcus pneumoniae distribution by Toll-like receptor 2 in vivo. Immunobiology. 210(2-4). 229–236. 14 indexed citations
16.
Echchannaoui, Hakim, Karl Frei, Maryse Letièmbre, et al.. (2005). CD14 deficiency leads to increased MIP-2 production, CXCR2 expression, neutrophil transmigration, and early death in pneumococcal infection. Journal of Leukocyte Biology. 78(3). 705–715. 27 indexed citations
17.
Laflamme, Nathalie, Hakim Echchannaoui, Régine Landmann, & Serge Rivest. (2003). Cooperation between toll‐like receptor 2 and 4 in the brain of mice challenged with cell wall components derived from gram‐negative and gram‐positive bacteria. European Journal of Immunology. 33(4). 1127–1138. 135 indexed citations
18.
Echchannaoui, Hakim, Karl Frei, Christian Schnell, et al.. (2002). Toll‐Like Receptor 2–Deficient Mice Are Highly Susceptible toStreptococcus pneumoniaeMeningitis because of Reduced Bacterial Clearing and Enhanced Inflammation. The Journal of Infectious Diseases. 186(6). 798–806. 246 indexed citations
19.
Haque, Azizul, et al.. (2001). Cerebral Malaria in Mice. American Journal Of Pathology. 158(1). 163–172. 22 indexed citations
20.
Lemaı̂tre, Jean-Paul, et al.. (1998). Plasmid-Mediated Resistance to Antimicrobial Agents among Listeriae. Journal of Food Protection. 61(11). 1459–1464. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laure Janot Breakdown of academic impact, for papers by David Torres Breakdown of academic impact, for papers by Megumi Inomata Breakdown of academic impact, for papers by Lorna Edwards Breakdown of academic impact, for papers by Stefan Dreher Breakdown of academic impact, for papers by M W Vermeulen Breakdown of academic impact, for papers by R. Lakshman Chelvarajan Breakdown of academic impact, for papers by Bas Baaten Breakdown of academic impact, for papers by Mary Speir
Rankless by CCL
2026